A novel technique using echocardiography to evaluate venous cannula
performance perioperatively in CPB cardiac surgery
David Jegger
a,*
, Pierre-Guy Chassot
b, Marc-Andre Bernath
b, Judith Horisberger
a,
Philippe Gersbach
a, Piergiorgio Tozzi
a, Dominique Delay
a, Ludwig K. von Segesser
aa
Department of Cardiovascular Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland
bDepartment of Anesthesiology, CHUV, Lausanne, Switzerland
Received 8 June 2005; received in revised form 6 November 2005; accepted 21 December 2005; Available online 14 February 2006
Abstract
Objective: Transthoracic echocardiography (TTE) has been used clinically to disobstruct venous drainage cannula and to optimise placement of venous cannulae in the vena cava but it has never been used to evaluate performance capabilities. Also, little progress has been made in venous cannula design in order to optimise venous return to the heart lung machine. We designed a self-expandable Smartcanula1
(SC) and analysed its performance capability using echocardiography. Methods: An epicardial echocardiography probe was placed over the SC or control cannula (CTRL) and a Doppler image was obtained. Mean (Vm) and maximum (Vmax) velocities, flow and diameter were obtained. Also, pressure drop
(DPCPB) was obtained between the central venous pressure and inlet to venous reservoir. LDH and Free Hb were also compared in 30 patients.
Comparison was made between the two groups using the student’s t-test with statistical significance established when p < 0.05. Results: Age for the SC and CC groups were 61.6 17.6 years and 64.6 13.1 years, respectively. Weight was 70.3 11.6 kg and 72.8 14.4 kg, respectively. BSA was 1.80 0.2 m2 and 1.82 0.2 m2, respectively. CPB times were 114 53 min and 108 44 min, respectively. Cross-clamp time was
59 15 min and 76 29 min, respectively ( p = NS). Free-Hb was 568 142 U/l versus 549 271U/l post-CPB for the SC and CC, respectively ( p = NS). LDH was 335 73 mg/l versus 354 116 mg/l for the SC and CC, respectively ( p = NS). Vmwas 89 10cm/s (SC) versus 63 3 cm/s
(CC), Vmaxwas 139 23 cm/s (SC) versus 93 11 cm/s (CC) (both p < 0.01). DPCPBwas 30 10 mmHg (SC) versus 43 13 mmHg (CC) ( p < 0.05).
A Bland—Altman test showed good agreement between the two devices used concerning flow rate calculations between CPB and TTE (bias 300 ml 700 ml standard deviation). Conclusions: This novel Smartcanula design, due to its self-expanding principle, provides superior flow characteristics compared to classic two stage venous cannula used for adult CPB surgery. No detrimental effects were observed concerning blood damage. Echocardiography was effective in analysing venous cannula performance and velocity patterns.
#2006 Elsevier B.V. All rights reserved.
Keywords: Cardiopulmonary bypass; Cardiotomy suction; Haemolysis; Blood
1. Introduction
The use of ultrasound techniques has become routine in cardiac surgery in order to help the clinicians in optimising diagnosis preoperatively (transthoracic echocardiography (TTE)) and perioperatively (transoesophageal echocardio-graphy (TOE)) by validating surgical techniques such as mitral valvuloplasties, identifying dyskinetic myocardial zones postcoronary artery bypass graft (CABG) procedures and assuring the absence of paravalvular leaks postvalve replacement.
Recently, its usefulness has been reviewed and demon-strated in off-pump coronary artery bypass (OPCAB)[1]and during on-pump cardiopulmonary bypass (CPB) procedures
[2].
Novel applications for TTE or TOE was already introduced several years ago such as evaluating the correct positioning of femoral CPB cannulae, ventricular assist device (VAD) and the intra aortic balloon pump catheter (IABP) [3,4]. With the inception of minimally invasive procedures such as Port-access, TOE was also utilised with success[5,6].
Recently, diverse applications such as placement of umbilical venous catheter, haemodialysis and jugular vein cannulation have been reported with TOE[7—9]. Specific to cardiac applications, TOE has been used to disobstruct venous drainage cannula and to optimise placement of venous cannulae in the inferior vena cava (IVC)[10—12].
Since the inception of CPB, little progress has been made in the design of venous cannula except for minimally invasive applications [13] and three-stage venous cannula [14]. However, a self-expanding cannula, Smartcanula1
(SC), was developed and tested using computational fluid dynamics (CFD) [15], in vitro [16] and in in vivo animal settings[17]. During all of the above tests, it was found to be www.elsevier.com/locate/ejcts
* Corresponding author. Tel.: +41 21 3142153; fax: +41 21 3142158. E-mail address: David.Jegger@chuv.hospvd.ch (D. Jegger).
1010-7940/$ — see front matter # 2006 Elsevier B.V. All rights reserved. doi:10.1016/j.ejcts.2005.12.050
superior compared to classic venous cannula used for CPB applications.
Therefore, the aim of this study was twofold: (1) to establish the feasibility of using echocardiography (E) to evaluate the performance of venous cannula; and (2) to compare the SC with a control one to establish which is superior.
2. Materials and methods
The study design was approved by the Institutional review board and the patient demographics are presented inTable 1. Block randomisation was carried out and divided into a treated group (SC, n = 7) and a control group (CTRL, n = 6). However, only selected surgeons were implicated in the study due to the novelty of the device and the need for adaptive learning. Block randomisation was previously defined [18]. Briefly, it randomises n individuals into k treatments, in blocks of size m. Randomisation reduces opportunities for bias and confounding in experimental designs, and leads to treatment groups, which are random samples of the population sampled, thus helping to meet assumptions of subsequent statistical analysis. Random allocation can be made in blocks in order to keep the sizes of treatment groups similar. In order to do this, you must specify a sample size that is divisible by the block size you choose. In turn you must choose a block size that is divisible by the number of treatment groups you specify. An advantage of small block sizes is that treatment group sizes are very similar. A
disadvantage of small block sizes is that it is possible to guess some allocations, thus reducing blinding in the trial. An alternative to using large block sizes is to use random sequences of block sizes. The random block size option selects block sizes of 2, 3, 4 or 5 at random. The randomisation proceeds by allocating random permutations of treatments within each block.
2.1. Anaesthesia technique
All patients received midazolam for premedication. Anaesthesia was induced in all patients with propofol or etomidate, opioids including fentanyl, and the muscle relaxants pancuronium or vecuronium. All necessary mon-itoring lines were then inserted, and anaesthesia was maintained with propofol infusion or with anaesthetic gas (isoflurane or sevoflurane), continuous infusion or repeated doses of opioids, and pancuronium or vecuronium adminis-tration as required.
2.2. Echocardiography technique
After rewarming but before weaning, a sterile sheath (Raucodrape1
, Lohmann & Rauscher International GmbH & Co, Rengsdorf, Germany) was passed to the surgeon into which the epicardial TTE probe (model 15-6L, Philips, Bo¨blingen, Germany) was inserted together with transonic gel. The probe was placed on the venous cannula at the outlet of the right atrium. Echocardiographic longitudinal and cross-sectional images are shown of the SC in situ (Fig. 1). A Hewlett-Packard TTE machine (Sonos 5500, Philips, Bo¨blingen, Germany) was used to perform the imaging with a frame rate of 50 Hz. Once visualisation of flow inside the cannula was possible, continual doppler imaging was performed to obtain the maximum velocity (Vmaxin cm/s) and mean velocity (Vmin cm/s)(Fig. 2). The
diameter of the cannula was calculated by using the pointer on the TTE machine thereby making the calculation of flow rate (QE and QCPB, subscript E denotes echocardiography
and subscript CPB denotes cardiopulmonary bypass, respectively) possible from the following formula: VTI (velocity time integral using Vm 60) CSA (cannula
surface area). Simultaneously, the pressure drop (DPCPB=
Pin Pout) between the right atrium and the inlet of the CPB
venous reservoir was calculated by placing a DLP pressure transducer at the inlet to the venous reservoir (DLP 60000, Grand Rapids, MI, USA). The Pin was the central venous
Table 1
Patient demographics and operative data of the study population
Group CTRL (n = 6) Group SC (n = 7)
Age (years) 64.6 13.1 61.6 17.6
Gender (male/female ratio) 6/0 4/3*
Body surface area (m2) 1.82 0.2 1.80 0.2
Ejection fraction (%) 58.4 8.6 55.0 10.4
CPB time (min) 108 44 114 53
Cross-clamp time (min) 76 29 59 15
Weight (kg) 72.8 14.4 70.3 11.6
CABG (n and %) 2 (33%) 2 (29%)
Valve (n and %) 1 (17%) 4 (57%)*
Combined (n and %) 2 (33%) 0 (0%)*
Other (n and %) 1 (17%) 1 (14%)
CTRL: control group versus SC: smartcanula group; CPB: cardiopulmonary bypass; CABG: coronary artery bypass graft.
* Statistical significance found between the two groups when p < 0.05.
pressure value (CVP) while the Poutwas the value indicated
on the DLP pressure transducer. 2.3. The SC device
The Smartcanula1
(Smartcanula Ltd, Fribourg, Switzer-land) is made of interlaced wires having memory shape properties. The one end is moulded into a plastic tip, the other end is siliconised to a 3/8-in. connector (Fig. 3). To insert the cannula in a vessel, a guide wire is placed to assure proper placement. The guide wire is inserted into the cannula’s tip and through an introducer used to flatten the cannula because of the cannula’s ability to change shape when placed under stress. Once the cannula is in place, the guide wire and introducer are removed, and it expands to a larger diameter value due to the fact that the stress is removed from the cannula’s structure. The circuit is now connected to the cannula’s outlet which is manufactured with a 3/8- or 1/2-in. connector.
2.4. Perfusion technique
A heart lung machine (Stockert Medizintechnik AG, Munich, Germany), a hollow fibre membrane oxygenator (D903 Dideco1, Mirandola, Italy or Quadrox1 Jostra Medizintechnik AG, Hirrlingen, Germany), a conventional tubing circuit (Dideco, Mirandola, Italy or Jostra Medizin-technik AG, Hirrlingen, Germany) and an air—oxygen
blender (Sechrist Industries, Inc., Anaheim, CA, USA) were used in all of the procedures. The extracorporeal circuit is primed with 1000 ml Ringer lactate, 500 ml Haes, 100 mg Heparin (Liquemin, Hoffmann-La Roche, Basel, Switzer-land), an antibiotic and 1 million IU Aprotinin (Trasylol, Bayer, Zu¨rich, Switzerland) following the departmental protocol.
2.5. Surgical technique
A midline sternotomy was performed. The pericardium opened anteriorly to the phrenic nerve to expose the right atrium and both venae cavae. Simultaneously, the arterial site was prepared to expose the aorta. The patient was anticoagulated with 3 mg/kg heparin (Liquemin, Hoffmann-La Roche, Basel, Switzerland) before cannulation of the aorta. Subsequent superior vena cava (SVC) and inferior vena cava (IVC) cannulation occurs or direct cannulation of the right atrium depending on the surgical procedure. CPB was initiated with passive venous drainage. The cardiac proce-dure was performed under direct vision. After rewarming and careful deairing manoeuvres by way of a vent placed in the ascending aorta, the aorta was unclamped. The weaning process was started once the patient was ventilated and cardiac rhythm reinitiated.
2.6. Measurements
Age, weight, body surface area (BSA), CPB and cross-clamp times were recorded. Vmax(cm/s), Vm(cm/s), DPCPB
(mmHg), diameter, CSA of analysed section (mm) and QE(l/
min) were also recorded. Free Hb and LDH values were also compared between the two groups.
2.7. Data analysis
(1) Mean and standard deviation were derived for each parameter analysed. An unpaired Student’s t-test and analysis of variance for repeated measures were used for determination of statistical significance between the two groups ( p < 0.05).
(2) We performed a Bland—Altman analysis between QCPB
and QErate (l/min) using GraphPad Prism version 4.00
for Windows (GraphPad Software, San Diego, CA, USA)
[19].
Fig. 2. Echocardiography images for the CTRL (A) and SC (B) showing velocity (mean and max) profile using continual Doppler imaging. Upper right hand image reflects the cannula’s wall section, while the bottom image reflects the velocity over time. Notice the greater velocities obtained with the SC. (C) The chattering phenomenon often encountered during the running of the CPB procedure. Notice how the excess negative pressure in the venous line provokes velocity variations over time.
Fig. 3. SC before insertion with a mandrel inside (top) and deployment when the mandrel is removed (bottom). The SC expands to take the shape of the inside lumen of the native vessel, i.e. the IVC (proximal end in this case).
3. Results
The patient demographics are presented in Table 1. Significant differences in patient demographics were observed between the two groups for gender, valve and combined procedures.
In order to exclude any detrimental effects of the wire-interlaced design on the intimal vessel wall, Free Hb and LDH values were both comparable between the two groups (Table 2). The SC expressed 30% greater Vmvalues and 33%
greater Vmax values compared to the CTRL ( p < 0.001,
Table 2). When DPCPB was analysed, lower values of
30 10 mmHg versus 43 13 mmHg were observed for the SC and CTRL, respectively ( p < 0.05,Table 2). QCPBwas
comp-arable between the two groups. However, QEwas significantly
different when compared between the two groups.
A Bland—Altman analysis showed good agreement between the two devices used concerning flow rate calculations between CPB and echocardiography (bias 300 700 ml standard deviation). This means that echocar-diography slightly underestimated actual flow rates (Fig. 4).
All patients underwent successful CPB weaning with minimal inotropic support and were transferred to the intensive care unit in a stable condition. There were no complications reported: neither postoperative organ dys-function nor any other complication related to this technique. Echocardiographic control at day 7 was normal in every patient. The mortality of the patients were zero in both groups; also the median hospital stay was 11 days for both groups.
4. Discussion
We were successfully able to evaluate venous cannula performance with the use of echocardiography. Moreover, the SC significantly outperformed the CTRL cannula with respect to all flow dynamic variables measured. No haemolysis was observed by the SC during the study period. During a numerical analysis using CFD, Mueller et al.[15]
established lower pressure gradients across the SC which we can advocate and validate in our study performed in a clinical setting with a 30% lower DPCPBobserved (Table 2). Moreover,
significantly greater mean and maximum velocities were attained for the SC for an equivalent flow rate when compared to the CTRL (Table 2). Due to the fact that higher velocities are measured within the SC, greater resistance to blood flow is encountered outside the patient or in the venous line. However, the DPCPBis lower; thus, resistance to blood
flow inside the patient (CVP) is lower which supports the superiority of the SC by showing its ability to reduce the CVP when compared to the CTRL cannula. Jegger et al.[16,17], also showed superiority of the SC in an in vitro setting demonstrating 14—19% greater flow rates depending on the preload used. This phenomenon was complemented by performing in vivo animal testing with the SC exhibiting a 20% greater flow rate capacity during passive and active venous drainage techniques [20]. Similar findings were encountered by Mueller et al. [21] in a parallel bovine experiment. Undertaking clinical comparisons is difficult as once theoretical flow is attained, it is also maintained. Nevertheless, comparable flow rates of 4.8 0.2 l/min and 4.4 0.5 l/min for the CTRL and SC, respectively, were obtained. In our study, no additional haemolysis was associated with the use of the SC compared to the CTRL as LDH and Free Hb values were comparable (Table 2). In addition, after each CPB procedure with the smartcannula, the cannula was examined macroscopically with no deposits being found. Also, the cannulae were rinsed and visually inspected again in the absence of any thrombotic material in or around the cannulae.
TTE has previously been reported by Grooters et al.[22]in a clinical setting analysing the velocities at the outlet of several commercially available arterial CPB cannula. The intention was to evaluate whether cannula design influenced velocities and thus reduced the tendency of atherosclerotic emboli being a major cause of morbidity and mortality in the cardiac surgical community. Also, TTE has already been utilised to improve outcome when used to guide aortic cannula during on-pump CABG procedures. The use of this technique significantly reduced perioperative stroke and death [2]. Recently, the use of intraoperative epiaortic Table 2
Free Hb (mg/l) and LDH (U/l), performance parameters compared between the two groups: Vmax(cm/s), Vm(cm/s), DPCPB(mmHg), diameter of analysed
section (cm) and CSA (cm2)
Free Hb (mg/l) LDH (U/l) Vm(cm/s) CTRL 549 271 354 116 63 3 SC 568 142 335 73 89 10y Diameter (cm) CSA (cm2) V max(cm/s) CTRL 1.27 1.27 93 11 SC 0.95 0.71 139 23y QE(ml/min) QCPB(ml/min) DPCPB(mmHg) CTRL 4800 200 4500 550 43 13 SC 3800 400y 4400 540 30 10*
Parameters indexed: Vmindexed to flow rate; Vmand QCPBindexed to diameter
and CSA.
* Statistical significance found between the two groups when p < 0.05. y
Statistical significance found between the two groups when p < 0.01.
Fig. 4. Bland—Altman analysis of QEand QCPB; subscript E denotes
echocar-diography and subscript CPB denotes cardiopulmonary bypass, respectively. The y-axis presents the differences between the two measuring techniques. The x-axis represents the mean values of the two measuring techniques. Dashed lines indicate mean differences; dotted lines indicate boundaries of two standard deviations of the differences.
ultrasonography (EAUS) has been reported to delineate aortic atheroma. A correlation was established between ather-omatous finding in the ascending aorta detected by EAUS and the presence of peripheral vascular disease. Additionally, surgical technique was altered in 24% of the population due to atheromatous finding. The changes in surgical technique included conversion from on-pump to OPCAB, change in cannulation, aortic cross-clamping or saphenous vein graft proximal anastomosis site. More importantly, no cerebral vascular accidents were observed in the patients with a pathologic aorta who were converted to off-pump CABG surgery[23].
This novel analysis has not been performed with venous cannula. However, TTE was used to determine the position of the cannula relative to the IVC or right hepatic vein (RHV). It was observed that malposition of the venous cannula into the RHV was observed in 10% of the study population. When analysing the data, it was also observed that the incidence was greater with single stage compared to two-stage cannula. It is speculated that position of the cannula deep inside the IVC is more deleterious than the positioning of it in the RHV[11].
Upon the onset of CPB or during vital manipulations during the surgical procedure, QCPBcan often take several seconds or
minutes to stabilise, which are represented by a constant level of blood in the venous reservoir. However, when QEis utilised,
it is performed instantaneously or in real time and the waiting period for stabilisation of blood in the venous reservoir is substantially reduced. This is advantageous as not only instantaneous flow is measured but also change in flow patterns, such as chattering (Fig. 3C), can be identified and corrected. This improves patient safety as venous drainage is optimised, maintained and assured during the CPB procedure. The TTE technique can be considered a valid one due to the fact that the Bland—Altman analysis depicts small bias values when comparing the two methods. Also, the standard deviation is less than 10% of the theoretical flow rates often observed during CPB.
In conclusion, this study emphasises the benefit of using TTE in evaluating venous cannula performance and at the same time could be used to visualise correct placement of it in the right atrium. More so, the SC outperforms the CTRL one using this novel technique. This unique Smartcanula design, due to its self-expanding principle, provides superior flow characteristics compared to classic two stage venous cannula used for adult CPB surgery. Additionally, no haemolysis was observed in this clinical setting.
Acknowledgement
Special thanks to Hewlett-Packard (Switzerland) for the loaning of the TTE probe during the duration of the study period.
References
[1] Chassot P-G, van der Linden P, Zaugg M, Mueller XM, Spahn DR. Off-pump coronary artery bypass surgery: physiology and anaesthetic management. Br J Anaesth 2004;92:400—13.
[2] Gold JP, Torres KE, Maldarelli W, Zhuravlev I, Condit D, Wasnick J. Improving outcomes in coronary surgery: the impact of echo-directed
aortic cannulation and perioperative hemodynamic management in 500 patients. Ann Thorac Surg 2005;78:1579—85.
[3] Orihashi K, Hong YW, Chung G, Sisto D, Goldiner PL, Oka Y. New applica-tions of two-dimensional transesophageal echocardiography in cardiac surgery. J Cardiothorac Vasc Anesth 1991;5:33—9.
[4] Simon P, Owen An, Moritz A, Rokitansky A, Laczkovics A, Wolner E, Mohl W. Transesophageal echocardiography evaluation in mechanically assisted circulation. Eur J Cardiothorac Surg 1991;5:492—7.
[5] Applebaum RM, Cutler WM, Bhardwaj N, Colvin SB, Galloway AC, Riba-kove GH, Grossi EA, Schwartz DS, Anderson RV, Tunick PA, Kronzon I. Utility of transesophageal echocardiography during port-access mini-mally invasive cardiac surgery. Am J Cardiol 1998;82:183—8.
[6] Schulze CJ, Wildhirt SM, Boehm DH, Weigand C, Kornberg A, Reich-ensperner H, Reichart B. Continious transesophageal echocardiography (TTE) monitoring during port-access cardiac surgery. Heart Surg Forum 1999;2:54—9.
[7] Ades A, Sable C, Cummings S, Cross R, Markle B, Martin G. Echocardio-graphic evaluation of umbilical venous catheter placement. J Perinatol 2003;23:24—8.
[8] Headley CM, Thompson CL, Carter M, Khan A, Wall BM. The role of real time ultrasound placement of cuffed-tunneled hemodialysis catheters Nephrol Nurs J 2004;31:416—9.
[9] Planinsic RM, Nicolau-Raducu R, Caldwell JC, Aggarwal S, Hilmi I. Trans-esophageal echocardiography-guided placement of internal jugular per-cutaneous venovenous bypass cannula in orthotopic liver transplantation. Anesth Analg 2003;97:648—9.
[10] Ranasinghe AM, Peek GJ, Roberts N, Chin D, Killer HM, Sosnowski AW, Firmin RK. The use of transesophageal echocardiography to demonstrate obstruction of venous drainage cannula during ECMO. ASAIO J 2004; 50:619—20.
[11] Kirkeby-Garstad I, Tromsdal A, Sellevold OFM, Bjorngaard M, Bjella LK, Berg EM, Karevold A, Haaverstad R, Wahba A, Tjomsland O, Astudillo R, Krogstad A, Stenseth R. Guiding surgical cannulation of the inferior vena cava with transesophageal echocardiography. Anesth Analg 2003; 96:1288—93.
[12] Sastre Rincon JA, Hernandez Valero A, Fernandez Perez A, Muriel Villoria C. A simple method to control a malposition of in ferior venous cannula in cardiac surgery using transesophageal echocardiography. Eur J Cardi-othorac Surg 2002;22:146.
[13] Jegger D, Tevaearai HT, Horisberger J, Boone Y, Pierrel N, von Segesser LK. Augmented venous return using a centrifugal pump during mini-mally invasive open heart surgery. Eur J Cardiothorac Surg 1999; 16:312—6.
[14] Medtronic MC2X Three stage venous cannula publicity brochure, 2003. Brochure No: UC200400882 EN. Medtronic, Minneapolis, MN, USA. [15] Mueller XM, Mallabiabarrena I, Mucciolo G, von Segesser LK.
Opti-mized venous return with a self-expanding cannula: from computa-tional fluid dynamics to clinical application. Int Cardiothorac Surg 2002;1:23—7.
[16] Jegger D, Tevaearai HT, Mueller XM, Mucciolo G, Boone Y, Seigneul I, Horisberger J, von Segesser LK. A new expandable cannula to increase venous return during peripheral access CPB surgery. Int J Artif Organs 2002;25:136—40.
[17] Jegger D, Mueller XM, Mucciolo G, Boone Y, Seigneul I, Horisberger J, von Segesser LK. A new pediatric peripheral access venous cannula which changes shape in situ. Perfusion 2003;18:61—5.
[18] Bland M. An introduction to medical statistics, 3rd ed., New York: Oxford Medical Publications; 2000.
[19] Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307—10. [20] Jegger D, Horisberger J, Mucciolo G, Mucciolo A, Boone Y, Jachertz M, Seigneul I, von Segesser LK. In vivo evaluation of paediatric venous cannulae using different drainage positions and height differential con-ditions. Swiss Surg 2003;9(Suppl. 1):2—32.
[21] Mueller XM, Tevaearai HT, Jegger D, Horisberger J, Mucciolo G, von Segesser LK. A new expandable venous cannula for minimal access heart surgery. Ann Thorac Surg 2002;74:S1330—3.
[22] Grooters RK, Ver Steeg DA, Stewart MJ, Thieman KC, Schneider RF. Echocardiographic comparison of the standard end-hole cannula, the soft-flow cannula, and the dispersion cannula during perfsuion into the aortic arch. Ann Thorac Surg 2003;75:1919—23.
[23] Bolotin G, Domany Y, de Perini L, Frolkis I, Lev-Ran O, Nesher N, Uretzky G. Use of intraoperative epiaortic ultrasonography to delineate aortic atheroma. Chest 2005;127(1):60—5.
